insights_auto
Why is XYF down 4,26%?
Dive Deeperchevron_right
XYF:NYSE
X Financial
4,94 US$
arrow_downward
-4,26%(-0,22) 1D
2 ოქტ, 16:00:05 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for XYF...
Open
5,13 US$
High
5,17 US$
Low
4,94 US$
Mkt. cap
193,09 მლნ.
Avg. vol.
73,14 ათ.
Volume
60,87 ათ.
Dividend
11,34%
Quarterly dividend
0,14 US$
Ex-dividend date
26 სექ. 2025
P/E ratio
2,41
52-wk high
14,86 US$
52-wk low
3,30 US$
EPS
2,05 US$
Beta
0,54
Shares outstanding
22,25 მლნ.
No. of employees
643
Open
5,13 US$
High
5,17 US$
Low
4,94 US$
Mkt. cap
193,09 მლნ.
Avg. vol.
73,14 ათ.
Volume
60,87 ათ.
Dividend
11,34%
Quarterly dividend
0,14 US$
Ex-dividend date
26 სექ. 2025
P/E ratio
2,41
52-wk high
14,86 US$
52-wk low
3,30 US$
EPS
2,05 US$
Beta
0,54
Shares outstanding
22,25 მლნ.
No. of employees
643
News stories
From web sources and news partners
GlobeNewswire
·
11 წუთის წინ
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance UK
·
11 წუთის წინ
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Intellia Therapeutics
·
10 წუთის წინ
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About X Financial